{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:23:40Z","timestamp":1770816220621,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ejso.2020.01.035","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:39:47Z","timestamp":1580989187000},"page":"1327-1333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1\/2 gene mutational status"],"prefix":"10.1016","volume":"46","author":[{"given":"V","family":"Gallotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MT","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Davi\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GF","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"De Bonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Capoluongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2020.01.035_bib1","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ejso.2020.01.035_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/annonc\/mdw663","article-title":"Participants of the fifth ovarian cancer consensus conference. Fifth ovarian cancer consensus conference of the gynecologic cancer InterGroup: recurrent disease","volume":"28","author":"Wilson","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.01.035_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2018.08.016","article-title":"Histotype classification of ovarian carcinoma: a comparison of approaches","volume":"151","author":"Peres","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib4","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.2147\/OTT.S102569","article-title":"Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer","volume":"10","author":"Hollis","year":"2017","journal-title":"OncoTargets Ther"},{"issue":"14","key":"10.1016\/j.ejso.2020.01.035_bib5","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Canc"},{"issue":"1","key":"10.1016\/j.ejso.2020.01.035_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ogc.2018.09.005","article-title":"Ovarian cancer: clinical trial breakthroughs and impact on management","volume":"46","author":"Previs","year":"2019","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.035_bib7","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejso.2020.01.035_bib8","series-title":"Abs.5501, ASCO meeting","article-title":"Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20","author":"Du Bois","year":"2017"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.035_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","article-title":"A\u00a0risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.01.035_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2014.09.017","article-title":"Impact of secondary cytoreductive surgery on survival in patients with platinum-sensitive recurrent ovarian cancer: analysis of the CALYPSO trial","volume":"136","author":"Lee","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2020.01.035_bib11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2020.01.035_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2013.06.020","article-title":"Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors","volume":"131","author":"Petrillo","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2020.01.035_bib13","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1245\/s10434-015-4523-2","article-title":"Secondary cytoreduction in platinum-resistant recurrent ovarian cancer: a single-institution experience","volume":"22","author":"Musella","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.035_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ygyno.2016.04.537","article-title":"Surgical management of recurrent ovarian cancer","volume":"142","author":"Suh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1245\/ASO.2004.11.023","article-title":"Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes","volume":"11","author":"Uzan","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ygyno.2006.10.020","article-title":"Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer","volume":"104","author":"Santillan","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2006.06.039","article-title":"Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors","volume":"104","author":"Blanchard","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1525-1438.2007.00929.x","article-title":"Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery","volume":"17","author":"Benedetti Panici","year":"2007","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.ejso.2020.01.035_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2009.04.025","article-title":"Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer","volume":"114","author":"Fotiou","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2020.01.035_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ejso.2013.11.026","article-title":"Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study","volume":"40","author":"Ferrero","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.01.035_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijgo.12667","article-title":"The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer","volume":"143","author":"Bogani","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejso.2020.01.035_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1471-2407-8-367","article-title":"Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome","volume":"8","author":"Legge","year":"2008","journal-title":"BMC Canc"},{"issue":"3","key":"10.1016\/j.ejso.2020.01.035_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ygyno.2009.11.008","article-title":"The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: a multicenter retrospective Italian study","volume":"116","author":"Gadducci","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijsu.2019.07.026","article-title":"Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: a systematic review of the literature","volume":"69","author":"Pergialiotis","year":"2019","journal-title":"Int J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2020.01.035_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0002-9378(97)70352-1","article-title":"Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance","volume":"176","author":"Kimball","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejso.2020.01.035_bib26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/IGC.0b013e31821e0353","article-title":"Comparison of the efficacy and toxicity between radiotherapy and chemotherapy in nodal and isolated nonnodal recurrence of ovarian cancer","volume":"21","author":"Lee","year":"2011","journal-title":"Int J Gynecol Canc"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.035_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ygyno.2014.05.029","article-title":"Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis","volume":"134","author":"Petrillo","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"16","key":"10.1016\/j.ejso.2020.01.035_bib28","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/cncr.32079","article-title":"High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum","volume":"125","author":"Hollis","year":"2019","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2020.01.035_bib29","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1245\/s10434-018-6700-6","article-title":"BRCA Mutation Status to personalize management of recurrent ovarian cancer: a multicenter Study","volume":"25","author":"Marchetti","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib30","unstructured":"Gallotta V, Conte C, D'Indinosante M, et\u00a0al. Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. Eur J Surg Oncol.S0748-7983(19)30517-7."},{"issue":"19","key":"10.1016\/j.ejso.2020.01.035_bib31","first-page":"30620","article-title":"Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse","volume":"s0002\u20139378","author":"Hollis","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.035_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"14","key":"10.1016\/j.ejso.2020.01.035_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143442","article-title":"BRCA1 and BRCA2 Testing through Next Generation Sequencing in a small cohort of Italian Breast\/Ovarian Cancer patients: novel pathogenic and unknown clinical significance variants","volume":"20","author":"Concolino","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejso.2020.01.035_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.seminoncol.2017.08.004","article-title":"Guidance statement on BRCA1\/2 tumor testing in ovarian cancer patients","volume":"44","author":"Capoluongo","year":"2017","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejso.2020.01.035_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","article-title":"Ovarian cancer patients with \u201cnode-positive-only\u201d Stage IIIC disease have a more favorable outcome than Stage IIIA\/B","volume":"107","author":"Ferrandina","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2020.01.035_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3802\/jgo.2008.19.4.223","article-title":"Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer","volume":"19","author":"Baek","year":"2008","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.01.035_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ejso.2020.01.035_bib38","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3892\/mmr.2015.3743","article-title":"Identification of lymphatic metastasis-associated genes in a metastatic ovarian cancer cell line","volume":"12","author":"Kang","year":"2015","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.ejso.2020.01.035_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jmig.2017.10.024","article-title":"Secondary laparoscopic cytoreduction in recurrent ovarian cancer: a large, single-institution experience","volume":"25","author":"Gallotta","year":"2018","journal-title":"J\u00a0Minim Invasive Gynecol"},{"issue":"10","key":"10.1016\/j.ejso.2020.01.035_bib40","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ejso.2018.08.006","article-title":"Minimally invasive salvage lymphadenectomy in gynecological cancer patients: a single institution series","volume":"44","author":"Gallotta","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.01.035_bib41","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00464-013-3390-9","article-title":"Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience","volume":"28","author":"Gallotta","year":"2014","journal-title":"Surg Endosc"},{"issue":"9","key":"10.1016\/j.ejso.2020.01.035_bib42","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A\u00a0randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2020.01.035_bib43","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jmig.2017.12.023","article-title":"Role of intraoperative ultrasound to extend the application of minimally invasive surgery for treatment of recurrent gynecologic cancer","volume":"25","author":"Mascilini","year":"2018","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.ejso.2020.01.035_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2017.05.022","article-title":"Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: perioperative and oncologic outcomes","volume":"146","author":"Eriksson","year":"2017","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320300718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320300718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:27Z","timestamp":1760060007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320300718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0748798320300718"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.035","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1\/2 gene mutational status","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}